Vaccines — Editors

Journal Contact
Vaccines Editorial Office
MDPI AG, St. Alban-Anlage 66, 4052 Basel, Switzerland
E-Mail: vaccines.botdefense.please.enable.javaScript.mdpi.com
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18
Ms. Qingjuan Yang
Assistant Editor
MDPI Tongzhou Office, Room 2207, Jincheng Center, No. 21 Cuijingbeili, Tongzhou District, Beijing 101101, China
Tel. +86 10 8152 1170; Fax: +86 10 5901 1089
E-Mail

Editor

Prof. Dr. Diane M. Harper
Editor-in-Chief
Professor of Family and Geriatric Medicine, Obstetrics and Gynecology, Bioengineering, Epidemiology and Population Health, Health Promotions and Behavioral Sciences, University of Louisville School of Medicine, 501 East Broadway, Louisville, KY 40202, USA
E-Mail
Interests: cervical cancer prevention; HPV vaccine, HPV prevention; HPV cure; CIN detection; CIN cure; quality of life; shared decision making; communications
Special Issues and Collections in MDPI journals

Editorial Board

Prof. Dr. Pedro L. Alonso
Barcelona Center for International Health Research(CRESIB), University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
Website | E-Mail
Interests: public health; host-pathogen interaction; Malaria; viral and bacterial infections; HIV/AIDS and STI’s
Dr. Rolf Billeskov
Department of Infectious Disease Immunology, Division of Vaccine, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark Institute of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
Website | E-Mail
Interests: immunology; T cells; tuberculosis; polyfunctionality of T cells; T cell avidity; vaccines
Dr. Joseph E. Blaney, Jr.
Emerging Viral Pathogens Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research Plaza, Room 1A-124, Fort Detrick, MD 21702, USA
E-Mail
Interests: Viral vaccines, pathogenesis of emerging viruses, biodefense, animal model development
Prof. Dr. Thierry Boon
de Duve Institute, Université Catholique de Louvain and Ludwig Institute for Cancer Research, Brussels Branch Avenue Hippocrate, 74 B1.74.03, B-1200 Brussels, Belgium
E-Mail
Interests: The work of our group is aimed at understanding why some metastatic melanoma patients show tumor regression following vaccination whereas most patients do not. Recent results suggest that a local immunosuppressive environment at the tumor sites may be the main barrier to the efficacy of immunotherapy.
Prof. Dr. Olga Borges
Center for Neuroscience and Cell Biology & Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
Website1 | Website2 | E-Mail
Interests: focussed on the development of polymeric carriers as adjuvants for mucosal vaccination (protein and DNA) and examination of the interactions of delivery systems with biological targets in vitro and in vivo
Special Issues and Collections in MDPI journals:
Special Issue: Nanoparticles to Co-Deliver Immunopotentiators and Antigens
Dr. Sandra S. Chaves
Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30333, USA
E-Mail
Interests: infectious disease epidemiology; influenza; duration of vaccine-induced immunity; influenza treatment; influenza prevention
Prof. Dr. C.A.H.H. (Toos) Daemen
Department of Medical Microbiology, University of Groningen, Groningen 9700 RB, The Netherlands
E-Mail
Interests: Cancer immunotherapy; therapeutic vaccines; HPV; Hepatitis C virus; intratumoral immune environment; alphavirus-based vaccines
Dr. Kristina De Paris
Department of Microbiology and Immunology and Center for AIDS Research, University of North Carolina at Chapel Hill , Burnett Womack Bldg., Rm 9029, 160 Dental Circle, CB #7292, Chapel Hill, NC 27599-7292, USA
Website | E-Mail
Interests: HIV/SIV pathogenesis; pediatric HIV vaccines; neonatal/ infant immune development; mucosal immunology
Dr. Genoveffa Franchini
Animal Models & Retroviral Vaccine Section, Vaccine Branch, National Cancer Institute, National Institute of Health, 9000 Rockville Pike, Bethesda MD, 20892, USA
Website | E-Mail
Interests: immunology, virology, vaccines; HTLV; SIV; animal models; vaccine development
Prof. Dr. Eli Gilboa
Department of Microbiology and Immunology, Dodson Interdisciplinary Immunotherapy Institute and the Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, 1550 NW 10th Avenue, Room 211, Papanicolaou Cancer Research Building, Miami, FL 33136, USA
Website | E-Mail
Interests: My laboratory is using murine tumor models to develop a multi-pronged strategy to elicit clinically-useful antitumor immune responses in cancer patients. The current main strategy is to develop immune modulatory agents composed of short oligonucleotides (siRNAs, aptamers, antagomirs) that are targeted to the tumor or the tumor-activated immune system by conjugation to oligonucleotide aptamer ligands
Prof. Dr. Marc P. Girard
University Paris 7, French National Academy of Medicine, 49 rue D'Aubigny, FR 69003 Lyon, France
Website | E-Mail
Interests: viral vaccine research and development: HIV vaccines, influenza vaccines, lentiviruses; vaccinology in general; and anti-viral immune responses: neutralizing antibodies, ADCC and ADCVI, CD8+ T cell responses, innate immunity responses, mucosal immunity
Prof. Dr. Paul Goepfert
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA
Website | E-Mail
Interests: CD8 T cells; CD4 T cells; HIV pathogenesis; HIV immunology; HIV vaccinology; Clinical vaccine trials
Dr. Martin Villalba Gonzalez
INSERM-UM1 U1040, Université de Montpellier 1, 34295 Montpellier Cedex 5, France
Website | E-Mail
Interests: antitumor immunotherapy; cell therapy; NK cell; monoclonal antibodies; antibody-dependent cell cytotoxicity; MAPK; metabolism; dichloroacetate
Dr. Elena A. Govorkova
Department of Infectious Diseases, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA
Website | E-Mail
Interests: antiviral drugs for the control of influenza infection, including H5N1 influenza viruses: assessment of antiviral drug efficacy in vitro and in vivo; evaluation of viral fitness; combination chemotherapy; influenza vaccines: immunogenicity and protective efficacy
Dr. Maria G. Isaguliants
Riga Stradins University, Ratsupites 5, Riga LV-1069, Latvia
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Nobelsvägen 16, Stockholm 17177, Sweden
Gamalya Research Center of Epidemiology and Microbiology, Gamaleya street 16, 123098 Moscow, Russia
Website | E-Mail
Interests: human immunodeficiency virus type 1; human hepatitis C virus; DNA vaccines; in vivo imaging,; T cell response; B cell response; mouse models; cancer; oxidative stress
Dr. Angelo A. Izzo
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA
Website | E-Mail
Interests: Tuberculosis immunity; animal models; vaccines
Prof. Dr. Chinnaswamy Jagannath
Department of Pathology and Laboratory Medicine, University of Texas Health Sciences Center, 6400 Fannin Street, MSB 2.200, Houston, TX 77030, USA
Website | E-Mail
Interests: vaccines for tuberculosis; TLR signaling and adjuvants; Th1 immunity and T cells; Dendritic cells and macrophages-pathogen survival
Special Issues and Collections in MDPI journals:
Special Issue: Tuberculosis Vaccines
Dr. Vjollca H. Konjufca
Department of Microbiology, Southern Illinois University, Carbondale, IL 62901, USA
Website | E-Mail
Interests: mucosal immunology; antibodies; nanoparticles; mucosal vaccines; prime-boost immunization; Salmonella pathogenesis; female reproductive tract; antigen uptake and transport; spleen; goblet cells
Dr. Florian Krammer
Icahn School of Medicine at Mount Sinai, New York, One Gustave L. Levy Place, 10029 NY, Box 1124, USA
Website | E-Mail
Interests: influenza virus; avian influenza; universal influenza virus vaccines; hemagglutinin; neuraminidase; stalk-reactive antibodies; zoonotic viral infections; emerging viruses; viral glycoproteins
Prof. Nirbhay Kumar
Department of Tropical Medicine, School of Public Health & Tropical Medicine, Director, Vector-Borne Infectious Diseases Research Center, Tulane University, 333 S. Liberty Street, Mail Code-8317, New Orleans, LA 70112, USA
Website | E-Mail
Interests: malaria; vaccines; immunology; genomics; helminthes and co-infection; malaria transmission; malaria drugs and diagnostics
Prof. Dr. Matti Osmo Antero Lehtinen
School of Health Sciences, University of Tampere, Sorinkatu 1, 33014 Tampere, Finland
Website | E-Mail
Interests: cancer; tumor viruses; immune response; infectious disease epidemiology; sexually transmitted infections; translational medicine
Prof. Dr. Margaret A. Liu
1 ProTherImmune, 3656 Happy Valley Road Lafayette, CA 94549, USA
2 Karolinska Institute, Stockholm SE-17177, Sweden
3. Adjunct Professor, Department of Microbiology and Immunology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 USA
Website | E-Mail
Interests: vaccine technologies; DNA vaccines; cellular immune responses; HIV Vvccines; global health
Special Issues and Collections in MDPI journals:
Special Issue: DNA Vaccines
Dr. Paola Massari
Integrative Physiology and Pathobiology, Tufts University School of Medicine, Jaharis, 501, 150 Harrison Avenue, Boston, MA 02111, USA
Website | E-Mail
Interests: bacterial pathogenicity; vaccines; infectious diseases; inflammation; immune responsw
Prof. Dr. Abu Salim Mustafa
Department of Microbiology, Faculty of Medicine, Kuwait University PO Box 24923, Safat 13110, Kuwait
Website | E-Mail
Interests: Tuberculosis; vaccines; immunodiagnosis; immuno-pathogenesis
Special Issues and Collections in MDPI journals:
Special Issue: Tuberculosis Vaccines
Prof. Dr. Toshi Nagata
Department of Health Science, Hamamatsu University School of Medicine, 1-20-1 Handa-yama, Higashi-ku, Hamamatsu 431-3192, Japan
E-Mail
Interests: intracellular bacteria; T cell responses; DNA vaccines; HLA; antigen presentation; tuberculosis
Prof. Dr. Sven-Eric Olsson
Karolinska Institute at Danderyd Hospital, SE-182 88 Stockholm, Sweden
E-Mail
Interests: HPV vaccines; dysplasias and treatment options; immunological memory; cervical cancer screeningHPV vaccines; dysplasias and treatment options; immunological memory; cervical cancer screening programmes programmes
Dr. Mark Pearson
Research Fellow, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia
Website | E-Mail
Interests: Mark’s major research focus involves looking at the functions of proteins from human parasites (specifically helminths, or worms) and how these molecules interact with the host immune system. He is particularly interested in understanding these processes in the context of developing vaccines against parasites of third world populations and finding novel therapies for autoimmune disorders such as asthma
Dr. Pedro A. Reche
Facultad de Medicina, Dpto. Microbiology I – Immunology, Universidad Complutense de Madrid, Pza. Ramón y Cajal, Ciudad Universitaria, Madrid 28040, Spain
Website | E-Mail
Interests: Immunoinformatics, protein engineering, antigen presentation and processing, HLA, epitope, prediction, immunotherapy, vaccines
Dr. Rachel L. Roper
Department of Microbiology and Immunology, Brody School of Medicine, Brody Women Faculty Committee, East Carolina University, Faculty Marshall, 600 Moye Blvd, Rm 5E106A mailstop 629, Greenville, NC 27834, USA
Website | E-Mail
Interests: poxviruses; vaccinia; vaccines; viral immunoregulation; antigen presentation; cancer vaccines; viral genomes
Prof. Dr. John K. Rose
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Website | E-Mail
Interests: virology; vaccine and gene expression vectors based on rhabdoviruses; membrane protein assembly, transport and targeting; viral assembly
Prof. Dr. Jagannadha Sastry
Department of Immunology and Department of Veterinary Sciences, The University of Texas MD Anderson Cancer Center, Room: SCR4.2013, Unit 902, 7455 Fannin, Houston, TX 77054, USA
Website | E-Mail
Interests: viral immunology; mucosal immunity; adjuvants; HIV; SIV; SHIV; HPV; T cells; vaccines
Prof. Dr. Pramod K. Srivastava
Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, CT 06030-1601, USA
Website | E-Mail
Interests: antigen presentation by MHC I and MHC II molecules; immune response to cancer; viral immunity and autoimmunity
Prof. Dr. Walter J. Storkus
Department of Dermatology, Immunology, Bioengineering and Pathology, University of Pittsburgh School of Medicine, W1151 Biomedical Sciences Tower, 200 Lothrop Street Pittsburgh, PA 15213, USA
Website | E-Mail
Interests: Cancer vaccine; Immunotherapy; Cytotoxic T Cells; Dendritic Cells; Epitope Spreading; Angiogenesis; Vascular Normalization
Dr. Stanley S. Tai
Department of Microbiology, College of Medicine, Howard University, 520 “W” Street, NW, Washington, DC 20059, USA
E-Mail
Interests: pneumococcal vaccine; respiratory bacterial pathogens; bacterial pathogenesis
Special Issues and Collections in MDPI journals:
Special Issue: Pneumococcal Vaccine in the 21st Century
Prof. Dr. Alfredo G. Torres
Department of Microbiology & Immunology and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555, USA
Website | E-Mail
Interests: Bacteria; Nanovaccines; pathogenesis; virulence factors; attenuated bacterial vaccines; reverse vaccinology; Burkholderia; pathogenic Escherichia coli
Prof. Dr. Sjoerd H. van der Burg
Department of Oncology, Section Experimental Cancer Immunology and Therapy, K1-P, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
Website | E-Mail
Interests: The aim of my laboratory is to optimally implement immunotherapy as treatment modality for patients with solid tumors. The program is focused on the exploration of key factors in host-tumor interactions that determine successes and failures in immune control of cancer in order to drive the improvement of our immunotherapeutic strategies against solid tumors. Keywords: therapeutic vaccines, immunotherapy, peptides, HPV, chronic viral infections, cancer
Dr. Wilmore C. Webley
Department of Microbiology, University of Massachusetts Amherst, 240 Thatcher Road, Amherst,MA 01003, USA
Website | E-Mail
Interests: Immunology; pathogenic bacteriology; vaccine display and delivery; Chlamydia Vaccine development; infectious asthma etiology; obesogenic adenoviruses
Prof. Dr. Zhou Xing
McMaster Immunology Research Centre, Department of Pathology & Molecular Medicine, Rm. MDCL-4012, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S 4K1, Canada
Website | E-Mail
Interests: infectious diseases; pulmonary infectious disease; T cell immunity; vaccines; mucosal vaccination
Dr. Shi-Yu Yang
Division of Surgery & Interventional Science, University College London, Rowland Hill Street, London, NW3 2PF, UK
Website | E-Mail
Interests: colorectal cancer, stem cells; regenerative medicine
Prof. Dr. XiaoJian Yao
Laboratory of Molecular Human Retrovirology, Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, 745 Bannatyne Avenue, Room 508, Basic Medical Science Building, Winnipeg, MB R3E 0J9, Canada
Website | E-Mail
Interests: Virus/host interactions required for HIV replication; Development of Anti-HIV vaccines; Anti-HIV gene therapy
Dr. Alexander Zakhartchouk
Vaccine and Infectious Disease Organization – International Vaccine Center (VIDO-InterVac),University of Saskatchewan,120 Veterinary Road Saskatoon, Saskatchewan S7N 5E3,Canada
Website | E-Mail
Interests: antiviral vaccines; Nidoviruses; Adenoviruses; virus-host cell interactions; vaccine and gene expression vectors based on adenoviruses
Prof. Dr. Massimo Zollo
Department of Molecular Medicine and Medical Biotechnology, Federico II Faculty of Naples, Italy
Website | E-Mail
Interests: Human Genetics; Functional Genomics and Biotechnology; Molecular Biology and Oncology; Tumor Microenvironment; Metastasis; Paediatric Brain tumours; cell immunology; metastatic niche

Journal Contact

MDPI AG
Vaccines Editorial Office
St. Alban-Anlage 66, 4052 Basel, Switzerland
vaccines.botdefense.please.enable.javaScript.mdpi.com
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
Editorial Board
Contact Details Submit to Vaccines
Back to Top